KLP Kapitalforvaltning
OLMA icon

KLP Kapitalforvaltning’s Olema Pharmaceuticals OLMA Stock Holding History

KLP Kapitalforvaltning’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$103K Hold
11,900
– – ﹤0.01% 2073
2026
Q2 		$149K Buy
11,900
+3,600
+43% +$48.2K ﹤0.01% 2002
2026
Q1 		$124K Buy
+8,300
New +$185K ﹤0.01% 1993
2025
Q1 		– Sell
-5,100
Closed -$29.7K – 2284
2024
Q4 		$29.7K Buy
+5,100
New +$50.9K ﹤0.01% 2278

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

KLP Kapitalforvaltning's OLMA Position: Q3 2026 in Review

KLP Kapitalforvaltning held its Olema Pharmaceuticals (OLMA) position steady in Q3 2026 at 11,900 shares worth $103K. The position accounts for ﹤0.01% of the portfolio, ranked #2073.

KLP Kapitalforvaltning first reported a position in OLMA in Q4 2024 and has held it in 4 quarters since. The position peaked at $149K in Q2 2026. 119 funds tracked by Wall St. Rank hold OLMA as of Q3 2026.

  • KLP Kapitalforvaltning held 11,900 shares of Olema Pharmaceuticals worth $103K as of Q3 2026.
  • KLP Kapitalforvaltning left its Olema Pharmaceuticals share count unchanged in Q3 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q3 2026, its #2073 holding.
  • KLP Kapitalforvaltning first reported a position in Olema Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • KLP Kapitalforvaltning's Olema Pharmaceuticals position peaked at $149K in Q2 2026.
  • 119 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q3 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q3 2026, filed 10 Nov 2026.